Market Cap (In KRW)
36.09 Billion
Revenue (In KRW)
8.42 Billion
Net Income (In KRW)
-20.31 Billion
Avg. Volume
1.8 Million
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 537.0-4050.0
- PE
- -
- EPS
- -
- Beta Value
- 0.061
- ISIN
- KR7241820000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ms. Soyeon Kim
- Employee Count
- -
- Website
- http://www.pclchip.com
- Ipo Date
- 2017-02-23
- Details
- PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers multiplex antibody and antigen diagnostic kits for the detection of antibodies to human immunodeficiency virus (HIV) 1 and 2, HBV, hepatitis C virus (HCV), and human T-lymphotropic virus 1 and 2, as well as antigens to HIV p24, HCV core, and HBV surface in human serum or plasma. It also provides Ai, an influenza A/B typing rapid diagnostic test kit; Cancer6, a multiple tumor markers screening kit; and sciLINER LATERAL FLOW DISPENSER, a dispenser for membrane materials with active visual drop volume control. In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified. PCL, Inc. is headquartered in Seoul, South Korea.
More Stocks
-
CSLMR
-
VIDHIING
-
ASLRFAlien Metals Ltd
ASLRF
-
PWF-PZPower Financial Corporation
PWF-PZ
-
TMMAGrupo TMM, S.A.B.
TMMA
-
INOH
-
039490Kiwoom Securities Co., Ltd.
039490
-
6763